Cargando…

Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review

OBJECTIVE: To study the benefits and harms of antipsychotics in drug-naïve patients with psychosis. METHODS: This study is a systematic review and meta-analysis of placebo-controlled trials. Main outcome measures: Mortality, activities of daily living, quality of life, core psychiatric events, and r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Danborg, P.B., Gøtzsche, P.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6971828/ https://www.ncbi.nlm.nih.gov/pubmed/31561392 http://dx.doi.org/10.3233/JRS-195063

Ejemplares similares

Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
por: Danborg, P.B., et al.
Publicado: (2019)

Impaired reproduction after exposure to ADHD drugs: Systematic review of animal studies
por: Danborg, Pia Brandt, et al.
Publicado: (2017)

Antipsychotic Drugs Efficacy in Dextromethorphan-Induced Psychosis
por: Zaremba, Malgorzata, et al.
Publicado: (2023)

Functional Connectivity in Antipsychotic-Treated and Antipsychotic-Naive Patients With First-Episode Psychosis and Low Risk of Self-harm or Aggression: A Secondary Analysis of a Randomized Clinical Trial
por: Chopra, Sidhant, et al.
Publicado: (2021)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

Multidimensional predictors of negative symptoms in antipsychotic-naive first-episode psychosis
por: Toll, Alba, et al.
Publicado: (2022)

Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patients
por: Wang, Juan, et al.
Publicado: (2013)

Abnormal reward prediction-error signalling in antipsychotic naive individuals with first-episode psychosis or clinical risk for psychosis
por: Ermakova, Anna O., et al.
Publicado: (2018)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

Hair cortisol in drug-naïve first-episode individuals with psychosis
por: Andrade, Elvis H., et al.
Publicado: (2016)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

The benefits of the Mediterranean diet in first episode psychosis patients taking antipsychotics
por: Vassilopoulou, Emilia, et al.
Publicado: (2022)

Benefits and harms of the human papillomavirus (HPV) vaccines: systematic review with meta-analyses of trial data from clinical study reports
por: Jørgensen, Lars, et al.
Publicado: (2020)

Presentation of benefits and harms of antidepressants on websites: A cross-sectional study
por: Demasi, Maryanne, et al.
Publicado: (2020)

Psychosis in Parkinson’s disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges
por: Waddington, John L.
Publicado: (2020)

Schneider’s first-rank symptoms as predictors of remission in antipsychotic-naive first-episode psychosis
por: Malinowski, Fernando R., et al.
Publicado: (2019)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu, Xiaoli, et al.
Publicado: (2014)

Insulin resistance in first episode antipsychotic naïve psychosis patients-A cross sectional study.
por: Akshatha, C J, et al.
Publicado: (2022)

T28. BENEFITS AND HARMS OF ANTIPSYCHOTICS IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH SCHIZOPHRENIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Hagi, Katsuhiko, et al.
Publicado: (2020)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Does long term use of psychiatric drugs cause more harm than good?
por: Gøtzsche, Peter C, et al.
Publicado: (2015)

Effects of Risperidone on Cytokine Profile in Drug-Naïve First-Episode Psychosis
por: Noto, Cristiano, et al.
Publicado: (2015)

Sexual Dysfunction in Drug-Naïve or Drug-Free Male Patients with Psychosis: Prevalence and Risk Factors
por: Ravichandran, Dhananjayan, et al.
Publicado: (2019)

Aberrant static and dynamic functional patterns of frontoparietal control network in antipsychotic‐naïve first‐episode psychosis subjects
por: Briend, Frederic, et al.
Publicado: (2020)

Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes
por: Omachi, Yoshie, et al.
Publicado: (2018)

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

T97. CANNABIS USE IMPACTS SYMPTOM PRESENTATION IN ANTIPSYCHOTIC NAIVE PATIENTS IN FIRST EPISODE OF PSYCHOSIS (FEP)
por: Coutinho, Luccas, et al.
Publicado: (2018)

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2023)

Brain responses to different types of salience in antipsychotic naïve first episode psychosis: An fMRI study
por: Knolle, Franziska, et al.
Publicado: (2018)

Antipsychotics for elderly with psychosis: Deprescribe or continue?
por: Mohr, P.
Publicado: (2021)

New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin
por: Caraci, Filippo, et al.
Publicado: (2020)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

M169. HIPPOCAMPAL GLUTAMATE AND HIPPOCAMPUS SUBFIELD VOLUMES IN ANTIPSYCHOTIC-NAIVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS
Publicado: (2020)

Antipsychotics for the management of psychosis in Parkinson's disease: systematic review and meta-analysis
por: Jethwa, Ketan Dipak, et al.
Publicado: (2015)

Polygenic risk score analyses of symptoms and treatment response in an antipsychotic-naive first episode of psychosis cohort
por: Santoro, Marcos Leite, et al.
Publicado: (2018)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten B., et al.
Publicado: (2020)

Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis
por: Petruzzelli, Maria Giuseppina, et al.
Publicado: (2018)

Are benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study
por: Jørgensen, Karsten Juhl, et al.
Publicado: (2007)

Association between Insertion-Deletion Polymorphism of the Angiotensin-Converting Enzyme Gene and Treatment Response to Antipsychotic Medications: A Study of Antipsychotic-Naïve First-Episode Psychosis Patients and Nonadherent Chronic Psychosis Patients
por: Nadalin, Sergej, et al.
Publicado: (2022)

S57. TREATMENT SATISFACTION IN ACUTE PHASE PSYCHOSIS: COMPARISON BETWEEN ANTIPSYCHOTIC NAïVE AND PREVIOUSLY MEDICATED PATIENTS
por: Stabell, Lena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kferhv8r4ad8j31pbtmnctkv0o